World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently- Infected Huh7 Cultures, Volume 8

By Jhaveri, Ravi

Click here to view

Book Id: WPLBN0003949426
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently- Infected Huh7 Cultures, Volume 8  
Author: Jhaveri, Ravi
Volume: Volume 8
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Jhaveri, R. (n.d.). Plos One : Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently- Infected Huh7 Cultures, Volume 8. Retrieved from http://www.nationalpubliclibrary.info/


Description
Description : Efforts to treat HCV patients are focused on developing antiviral combinations that lead to the eradication of infection. Thus, it is important to identify optimal combinations from the various viral inhibitor classes. Based on viral dynamic models, HCV entry inhibitors are predicted to reduce viral load in a monophasic manner reflecting the slow death rate of infected hepatocytes (t1/2 = 2–70 days) and the protection of naı¨ve, un-infected cells from HCV infection. In contrast, replication inhibitors are predicted to reduce viral load in a biphasic manner. The initial rapid reduction phase is due to the inhibition of virus production and elimination of plasma virus (t1/2,3 hours). The second, slower reduction phase results from the elimination of infected hepatocytes. Here we sought to compare the ability of HCV entry and replication inhibitors as well as combinations thereof to reduce HCV infection in persistently-infected Huh7 cells. Treatment with 56EC50 of entry inhibitors anti-CD81 Ab or EI-1 resulted in modest (#1 log10 RNA copies/ml), monophasic declines in viral levels during 3 weeks of treatment. In contrast, treatment with 56EC50 of the replication inhibitors BILN-2016 or BMS-790052 reduced extracellular virus levels more potently (,2 log10 RNA copies/ml) over time in a biphasic manner. However, this was followed by a slow rise to steady-state virus levels due to the emergence of resistance mutations. Combining an entry inhibitor with a replication inhibitor did not substantially enhance the rate of virus reduction. However, entry/replication inhibitor and replication/replication inhibitor combinations reduced viral levels further than monotherapies (up to 3 log10 RNA copies/ml) and prolonged this reduction relative to monotherapies. Our results demonstrated that HCV entry inhibitors combined with replication inhibitors can prolong antiviral suppression, likely due to the delay of viral resistance emergence.

 

Click To View

Additional Books


  • Plos One : Antagonistic Regulation, Yet ... (by )
  • Plos One : Isocitrate Dehydrogenase from... (by )
  • Plos One : Human Cells Display Reduced A... (by )
  • Plos One : Deregulated Nras Expression i... (by )
  • Plos One : the Interaction of Helicobact... (by )
  • Plos One : Recruiting at the Edge ; Kine... (by )
  • Plos One : Minor Ailments in Pregnancy A... (by )
  • Plos One : Reassortment Between Avian H5... (by )
  • Plos One : Reduction of Type IV Collagen... (by )
  • Plos One : Polycomb Group Proteins Bind ... (by )
  • Plos One : Sequences Located Within the ... (by )
  • Plos One : Human Alveolar Epithelial Cel... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from National Public Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.